Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

WGS

GeneDx (WGS)

GeneDx Holdings Corporation
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:WGS
일자시간출처헤드라인심볼기업
2024/05/2305:05GlobeNewswire Inc.GeneDx to Participate in Upcoming Investor ConferencesNASDAQ:WGSGeneDx Holdings Corporation
2024/04/3005:05GlobeNewswire Inc.GeneDx Reports First Quarter 2024 Financial Results and Business HighlightsNASDAQ:WGSGeneDx Holdings Corporation
2024/04/2321:30GlobeNewswire Inc.GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease DatasetNASDAQ:WGSGeneDx Holdings Corporation
2024/04/0505:05GlobeNewswire Inc.GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024NASDAQ:WGSGeneDx Holdings Corporation
2024/03/1421:30GlobeNewswire Inc.GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of GenomicsNASDAQ:WGSGeneDx Holdings Corporation
2024/03/0606:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
2024/02/2706:05GlobeNewswire Inc.GeneDx to Participate in 44th Annual Cowen Health Care ConferenceNASDAQ:WGSGeneDx Holdings Corporation
2024/02/2406:56Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:WGSGeneDx Holdings Corporation
2024/02/2106:28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:WGSGeneDx Holdings Corporation
2024/02/2106:26GlobeNewswire Inc.GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024NASDAQ:WGSGeneDx Holdings Corporation
2024/02/0206:30GlobeNewswire Inc.GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024 NASDAQ:WGSGeneDx Holdings Corporation
2024/01/2506:30GlobeNewswire Inc.GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:WGSGeneDx Holdings Corporation
2024/01/2406:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
2024/01/0822:58Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:WGSGeneDx Holdings Corporation
2024/01/0822:55GlobeNewswire Inc.GeneDx Announces Preliminary 2023 Financial ResultsNASDAQ:WGSGeneDx Holdings Corporation
2024/01/0507:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
2024/01/0406:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
2023/12/2011:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
2023/12/2011:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
2023/12/1306:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
2023/12/1306:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
2023/12/0606:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
2023/12/0122:30GlobeNewswire Inc.GeneDx Presents New Data at the American Epilepsy Society Annual Meeting Demonstrating That Exome Sequencing Outperforms Multi-Gene Panels for Patients with EpilepsyNASDAQ:WGSGeneDx Holdings Corporation
2023/11/2906:05GlobeNewswire Inc.GeneDx to Participate in 6th Annual Evercore ISI HealthCONx ConferenceNASDAQ:WGSGeneDx Holdings Corporation
2023/11/2106:05GlobeNewswire Inc.GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:WGSGeneDx Holdings Corporation
2023/11/1806:15Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:WGSGeneDx Holdings Corporation
2023/11/0405:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:WGSGeneDx Holdings Corporation
2023/10/3105:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:WGSGeneDx Holdings Corporation
2023/10/3105:05GlobeNewswire Inc.GeneDx Reports Third Quarter 2023 Financial Results and Business HighlightsNASDAQ:WGSGeneDx Holdings Corporation
2023/10/2406:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
 검색 관련기사 보기:NASDAQ:WGS